Patent · US Active

Vaccine comprising Streptococcus pneumoniae capsular polysaccharide conjugates

US10279033B2 · kind B2 · utility

5Cited by

15References

1Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventors

Ralph Leon Biemans · Rixensart, BE
Nathalie Garcon · Rixensart, BE
Philippe Vincent Hermand · Rixensart, BE
Jan Poolman · Broek in Waterland, NL
Marcelle Paulette Van Mechelen · Rixensart, BE

Key dates

Filing date	Jan 5, 2016
Grant date	May 7, 2019
Priority date	—
Expiry date	Jan 5, 2036

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention discloses an immunogenic composition comprising S. pneumoniae capsular saccharide conjugates from serotypes 19A and 19F wherein 19A is conjugated to a first bacterial toxoid and 19F is conjugated to a second bacterial toxoid. Vaccines, methods of making vaccines and uses of the vaccines are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.